Related Parties

3 Months Ended

Mar. 31, 2020

19. Related Parties

HC2

In January 2015, the Company entered into a services agreement (the "Services Agreement") with Harbinger Capital Partners ("HCP"), a related party of the Company, with respect to the provision of services that may include providing office space and operational support and each party making available their respective employees to provide services as reasonably requested by the other party, subject to any limitations contained in applicable employment agreements and the terms of the Services Agreement. The Company recognized expenses of $0.7 million and $1.0 million and income of zero and $0.1 million for the three months ended March 31, 2020 and 2019, respectively.


	Three Months Ended March 31,
	2020										2019
	Corporate		Other ⁽¹⁾		Total		Corporate		Other ⁽¹⁾		Total
Allocated to HC2 by HCP
Office space	$	0.5	$	0.2	$	0.7	$	0.7	$	0.2	$	0.9
Administrative salaries and benefits	—		—		—		0.1		—		0.1
Other shared overhead	—		—		—		—		—		—
Total Expenses	0.5		0.2		0.7		0.8		0.2		1.0

Charged back to HCP by HC2
Administrative salaries and benefits	—		—		—		—		—		—
Other shared overhead	—		—		—		0.1		—		0.1
Total Income	—		—		—		0.1		—		0.1

Net related party activity	$	0.5	$	0.2	$	0.7	$	0.7	$	0.2	$	0.9

⁽¹⁾ Other in the above table represent certain entities within our Broadcasting, Life Sciences and Insurance segments.

Other

GMH''s subsidiary GMSL, prior to its sale in February 2020, had transactions with several of its equity method investees. A summary of transactions with such equity method investees and balances outstanding are as follows (in millions). Such activity is reclassified to discontinued operations as a result of the sale of GMSL. See note 3. Discontinued Operations for further information:


	Three Months Ended March 31,
	2020		2019
Net revenue	$	0.7	$	2.0
Operating expenses	$	—	$	0.6
Interest expense	$	0.1	$	0.3


	March 31,		December 31,
	2020		2019
Accounts receivable	$	—	$	1.2
Debt obligations	$	—	$	22.5
Accounts payable	$	—	$	0.1
Dividends	$	—	$	4.5

Life Sciences

Pansend has an investment in Triple Ring Technologies, Inc. ("Triple Ring"). Various subsidiaries of HC2 utilize the services of Triple Ring, incurring $0.7 million and zero in services for the three months ended March 31, 2020 and 2019, respectively.